학술논문

Eligibility for 177Lu-PSMA therapy depends on the choice of companion diagnostic tracer: a comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in metastatic castrate resistant prostate cancer
Document Type
Article
Source
In: Journal of Nuclear Medicine. (Journal of Nuclear Medicine, 1 February 2023, 64(2))
Subject
Language
English
ISSN
2159662X
01615505